Long acting reversible contraceptives (LARC) include Intrauterine devices/systems (e.g. Copper coil and progestogen containing intra-uterine systems (IUS) such as Mirena IUS), subdermal progestogen implants (e.g. nexplanon) and depot progestogen injections (Depo-Provera). There is a lack of clear guidance if a LARC has to be discontinued prior to ovarian stimulation for women donating their eggs or having fertility preservation, and anecdotally, we have come across some variation in clinical practice.
We would be grateful if you could answer these questions to enable a better picture to be built of policy practices so that future guidance on this question can be developed.